2-(3-(But-3-yn-1-yl)-3H-diazirin-3-yl)ethanamine hydrochloride

Catalog No. :
ACPCSX724
CAS No. :
2089291-69-8
Molecular Formula :
C7H12ClN3
Molecular Weight :
173.65

IUPAC Name:2-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)ethan-1-amine hydrochloride

2-(3-(But-3-yn-1-yl)-3H-diazirin-3-yl)ethanamine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$135.00Login to see priceIn stockInquiry
100mg97%$204.00Login to see priceIn stockInquiry
250mg97%$411.00Login to see priceIn stockInquiry
1g97%$1221.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-(But-3-yn-1-yl)-3H-diazirin-3-yl)ethanamine hydrochloride
IUPAC Name2-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)ethan-1-amine hydrochloride
MDL No.MFCD30005612
Molecular FormulaC7H12ClN3
Molecular Weight173.65
SMILESNCCC1(CCC#C)N=N1.[H]Cl
InChI KeyOXSFKWVZMRKXIO-UHFFFAOYSA-N
Synonym2-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)ethan-1-amine hydrochloride;2-(3-but-3-ynyldiazirin-3-yl)ethanamine;2-(3-(But-3-yn-1-yl)-3H-diazirin-3-yl)ethanamine hydrochloride;2-[3-(3-Butyn-1-yl)-3H-diazirin-3-yl]ethanamine Hydrochloride
CAS No.2089291-69-8

Safety Data

Pictogram
FlammableHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H228-H315-H319
Precautionary Statement(s)
P210-P240-P241-P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P370+P378

Synthetic Route by SureRoute

1. ACPCSX724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPCSX724 route product structure diagram
    ACPCSX7242089291-69-8 In Stock
Inquiry

2. ACPCSX724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPCSX724 route product structure diagram
    ACPCSX7242089291-69-8 In Stock
Inquiry

Comments (0)